- All sections
- A - Human necessities
- A01N - Preservation of bodies of humans or animals or plants or parts thereof biocides, e.g. as disinfectants, as pesticides or as herbicides pest repellants or attractantsplant growth regulators
- A01N 1/122 - Preservation or perfusion media
Patent holdings for IPC class A01N 1/122
Total number of patents in this class: 126
10-year publication summary
|
2
|
5
|
8
|
16
|
7
|
13
|
13
|
6
|
23
|
29
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hemanext Inc. | 99 |
6 |
| AxoGen Corporation | 259 |
4 |
| University Health Network | 1070 |
4 |
| The General Hospital Corporation | 4890 |
3 |
| The Regents of the University of California | 20902 |
2 |
| The Trustees of Columbia University in the City of New York | 3652 |
2 |
| University of Florida Research Foundation, Inc. | 4207 |
2 |
| DEKA Products Limited Partnership | 1913 |
2 |
| Lifeline Scientific, Inc. | 130 |
2 |
| LifeNet Health | 287 |
2 |
| NextGen Jane, Inc. | 20 |
2 |
| The Regents of the University of Colorado, a body corporate | 2846 |
2 |
| Transmedics, Inc. | 105 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3015 |
2 |
| United Therapeutics Corporation | 334 |
2 |
| The University of British Columbia | 1554 |
2 |
| University of Cincinnati | 933 |
2 |
| Yale University | 2569 |
2 |
| Mallinckrodt Pharmaceuticals Ireland Ltd | 234 |
2 |
| Restoration Biologics LLC | 8 |
2 |
| Other owners | 77 |